(S)-tert-Butyl 6-amino-2-((tert-butoxycarbonyl)amino)hexanoate

Catalog No. :
ACCMQT378
CAS No. :
7750-42-7
Molecular Formula :
C15H30N2O4
Molecular Weight :
302.42

IUPAC Name:tert-butyl (tert-butoxycarbonyl)-L-lysinate

(S)-tert-Butyl 6-amino-2-((tert-butoxycarbonyl)amino)hexanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$71.00Login to see priceIn stockIn stock
25g98%$348.00Login to see priceIn stockIn stock
100g98%$926.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl 6-amino-2-((tert-butoxycarbonyl)amino)hexanoate
IUPAC Nametert-butyl (tert-butoxycarbonyl)-L-lysinate
MDL No.MFCD28963513
Molecular FormulaC15H30N2O4
Molecular Weight302.42
SMILESO=C(OC(C)(C)C)[C@@H](NC(OC(C)(C)C)=O)CCCCN
InChI KeyLVUBESNUUMLEHL-NSHDSACASA-N
Synonymtert-butyl (2S)-6-amino-2-{[(tert-butoxy)carbonyl]amino}hexanoate;(S)-tert-Butyl 6-amino-2-((tert-butoxycarbonyl)amino)hexanoate;(Tert-Butoxy)Carbonyl Lys-OtBu (Syrup);tert-butyl N-tert-butyloxycarbonyl-L-lysinate;Boc-Lys-OtBu (Syrup);L-Lysine, N2-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester;N-Boc-Lysine Tert-butyl Ester;N2-Boc-L-lysine tert-butyl ester
CAS No.7750-42-7
PubChem CID10470194

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCMQT378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCMQT378 route product structure diagram
    ACCMQT3787750-42-7 In Stock
Inquiry

2. ACCMQT378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCMQT378 route product structure diagram
    ACCMQT3787750-42-7 In Stock
Inquiry

Comments (0)